檢索結果 - Yi‐Hsiang Huang

Refine Results
  1. 1
    Gastrointestinal and liver manifestations in patients with COVID-19

    Gastrointestinal and liver manifestations in patients with COVID-19 由 I‐Cheng Lee, Teh‐Ia Huo, Yi‐Hsiang Huang

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells

    Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells 由 Laura Airas, Maija Saraste, Sanna Rinta, Irina Elovaara, Yi‐Hsiang Huang, Heinz Wiendl

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma

    Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma 由 Mir Lim, Magdalena Espinoza, Yi‐Hsiang Huang, Joseph W. Franses, Hao Zhu, David Hsiehchen

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends, collaborations, and future avenues

    A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends, collaborations, and future avenues 由 Yi‐Hsiang Huang, Chengxiao Liao, Zefeng Shen, Yitong Zou, Weibin Xie, Qinghua Gan, Yuhui Yao, Junjiong Zheng, Jianqiu Kong

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma

    Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma 由 Pei‐Chang Lee, Yee Chao, Ming‐Huang Chen, Keng‐Hsin Lan, I‐Cheng Lee, Ming‐Chih Hou, Yi‐Hsiang Huang

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    The oral microbiome in autoimmune diseases: friend or foe?

    The oral microbiome in autoimmune diseases: friend or foe? 由 Xiaoyan Huang, Xiang‐Yu Huang, Yi‐Hsiang Huang, Jiarong Zheng, Lu Ye, Zizhao Mai, Xinyuan Zhao, Li Cui, Shaohong Huang

    出版 2023
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments

    Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments 由 I‐Cheng Lee, Yi‐Hsiang Huang, Gar‐Yang Chau, Teh‐Ia Huo, Chien‐Wei Su, Jaw‐Ching Wu, Han‐Chieh Lin

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    The effect of oropharyngeal colostrum administration on the clinical outcomes of premature infants: A meta-analysis

    The effect of oropharyngeal colostrum administration on the clinical outcomes of premature infants: A meta-analysis 由 Zhen Yan Fu, Chi Huang, Lei Lei, Li Cheng Chen, Wei Li, Jiao Zhou, Ming Tao, Ming Tao Quan, Yi‐Hsiang Huang

    出版 2023
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis

    Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis 由 Yin-Chen Wang, Sien-Sing Yang, Chien–Wei Su, Yuan-Jen Wang, Kuei‐Chuan Lee, Teh‐Ia Huo, Han‐Chieh Lin, Yi‐Hsiang Huang

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients undergoing Biologics Treatment

    Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients undergoing Biologics Treatment 由 Ming‐Han Chen, Ming‐Huang Chen, Chun‐Yu Liu, Chang‐Youh Tsai, De-Feng Huang, Hsiao-Yi Lin, Mei–Hsuan Lee, Yi‐Hsiang Huang

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma

    A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma 由 Shu‐Yein Ho, Po‐Hong Liu, Chia-Yang Hsu, Yi‐Hsiang Huang, Jia‐I Liao, Chien–Wei Su, Ming‐Chih Hou, Teh‐Ia Huo

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma

    Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma 由 Chi-Jung Wu, Pei‐Chang Lee, Ya‐Wen Hung, Chieh-Ju Lee, Chen‐Ta Chi, I‐Cheng Lee, Ming‐Chih Hou, Yi‐Hsiang Huang

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

    Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 由 Shu‐Yein Ho, Po‐Hong Liu, Chia-Yang Hsu, Yi‐Hsiang Huang, Jia‐I Liao, Chien–Wei Su, Ming‐Chih Hou, Teh‐Ia Huo

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience

    Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience 由 Wen‐Chi Wu, Tzu-Yuan Lin, Ming‐Huang Chen, Yi‐Ping Hung, Chien‐An Liu, Rheun‐Chuan Lee, Yi‐Hsiang Huang, Yee Chao, San‐Chi Chen

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma

    Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma 由 Pei‐Chang Lee, Yee Chao, Ming‐Huang Chen, Keng‐Hsin Lan, Chieh-Ju Lee, I‐Cheng Lee, San‐Chi Chen, Ming‐Chih Hou, Yi‐Hsiang Huang

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Genotypes and Viremia of Hepatitis B and D Viruses Are Associated With Outcomes of Chronic Hepatitis D Patients

    Genotypes and Viremia of Hepatitis B and D Viruses Are Associated With Outcomes of Chronic Hepatitis D Patients 由 Chien‐Wei Su, Yi‐Hsiang Huang, Teh‐Ia Huo, Hsuan Hui Shih, I‐Jane Sheen, Su–Wen Chen, Pui–Ching Lee, Shou–Dong Lee, Jaw‐Ching Wu

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Using Serum α-Fetoprotein for Prognostic Prediction in Patients with Hepatocellular Carcinoma: What is the Most Optimal Cutoff?

    Using Serum α-Fetoprotein for Prognostic Prediction in Patients with Hepatocellular Carcinoma: What is the Most Optimal Cutoff? 由 Chia‐Yang Hsu, Po‐Hong Liu, Yun-Hsuan Lee, Cheng‐Yuan Hsia, Yi‐Hsiang Huang, Han‐Chieh Lin, Yi‐You Chiou, Fa‐Yauh Lee, Teh‐Ia Huo

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients

    Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients 由 Yee Chao, Wing‐Kai Chan, MJ Birkhofer, OY-P Hu, S. S. Wang, Yi‐Hsiang Huang, Maiqi Liu, Jacqueline Whang‐Peng, K-H Chi, W‐Y Lui, S. D. Lee

    出版 1998
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems

    Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems 由 Po‐Hong Liu, Chia‐Yang Hsu, Cheng‐Yuan Hsia, Yun-Hsuan Lee, Chien‐Wei Su, Yi‐Hsiang Huang, Fa‐Yauh Lee, Han‐Chieh Lin, Teh‐Ia Huo

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy

    Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy 由 Po‐Hong Liu, Chien–Wei Su, Chia‐Yang Hsu, Cheng‐Yuan Hsia, Yun-Hsuan Lee, Yi‐Hsiang Huang, Rheun‐Chuan Lee, Han‐Chieh Lin, Teh‐Ia Huo

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: